Skip to main navigation Skip to search Skip to main content

PET/MR Imaging of the Pancreas

Research output: Contribution to journalReview articlepeer-review

Abstract

PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.

Original languageEnglish (US)
Pages (from-to)345-362
Number of pages18
JournalMagnetic Resonance Imaging Clinics of North America
Volume26
Issue number3
DOIs
StatePublished - Aug 2018

Funding

Disclosure: Dr T.A. Hope has received grant support from GE Healthcare ; Dr A.R. Guimaraes is affiliated with Siemens Speaker’s Bureau, AGFA Imaging, Merck Pharmaceuticals, Inc; Dr N. Mallak has nothing to disclose.

Funders
GE Healthcare

    Keywords

    • DOTATATE
    • Neuroendocrine tumor
    • PET/MR imaging
    • Pancreas

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging

    Fingerprint

    Dive into the research topics of 'PET/MR Imaging of the Pancreas'. Together they form a unique fingerprint.

    Cite this